Background Currently no effective antiviral therapy has been found to treat COVID-19. The
aim of this trial was to assess if the addition of sofosbuvir and daclatasvir improved clinical …

Background New therapeutic options are urgently needed to tackle the novel coronavirus
disease 2019 (COVID-19). Repurposing existing pharmaceuticals provides an immediate …

Introduction Effective treatments are urgently needed to tackle the novel coronavirus disease
2019 (COVID-19). This trial aims to evaluate sofosbuvir and daclatasvir versus standard …

Objectives Sofosbuvir and daclatasvir are direct-acting antivirals highly effective against
hepatitis C virus. There is some in silico and in vitro evidence that suggests these agents …

Despite aggressive efforts on containment measures for the coronavirus disease 2019
(COVID-19) pandemic around the world, severe acute respiratory syndrome coronavirus 2 …

Abstract Background Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …

Statement of Retraction We, the Editors and Publisher of Expert Review of Anti-Infective
Therapy, have retracted the following article: Mahmoud El-Bendary, Sherief Abd-Elsalam …

Background Current approaches of drug repurposing against COVID-19 have not proven
overwhelmingly successful and the SARS-CoV-2 pandemic continues to cause major global …

The unprecedented challenge faced by mankind due to emergence of coronavirus 2019
(COVID-19) pandemic has obligated researchers across the globe to develop effective …

To date, there is no final FDA-approved treatment for COVID-19. There are thousands of
studies published on the available treatments for COVID-19 virus in the past year. Therefore …